PHARMACOKINETICS OF PROSCILLARIDIN-A IN MAN

被引：10

作者：

ANDERSSON, KE

BERTLER, A

REDFORS, A

机构：

[1] UNIV HOSP LUND,DEPT CLIN PHARMACOL,LUND,SWEDEN

[2] UNIV HOSP LUND,DEPT INTERN MED,LUND,SWEDEN

来源：

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1975年 / 8卷 / 06期

关键词：

D O I：

10.1007/BF00562316

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：421 / 425

页数：5

共 18 条

[1]

ANDERSSON K, IN PRESS

[2] INVITRO STABILITY OF PROSCILLARIDIN A [J].

ANDERSSON, KE ;

BERTLER, A ;

REDFORS, A .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 8 (02) :135-139

[3]

Belz G G, 1968, Med Klin, V63, P96

[4] PLASMA-LEVELS AFTER A SINGLE ORAL DOSE OF PROSCILLARIDIN [J].

BELZ, GG ;

STAUCH, M ;

RUDOFSKY, G .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1974, 7 (02) :95-97

[5]

BERTLER A, 1970, CLIN PHARMACOL THER, V11, P665

[6] THERAPEUTIC EFFICACY OF PROSCILLARIDIN A [J].

BUTZENGEIGER, KH ;

GRAEBER, U ;

LANGE, J ;

SCHUMACHER, R .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1967, 92 (48) :2212-+

[7]

BUTZENGEIGER KH, 1967, DTSCH MED WSCHR, V92, P2217

[8] STUDIES WITH TRITIATED DIGOXIN IN HUMAN SUBJECTS AFTER INTRAVENOUS ADMINISTRATION [J].

DOHERTY, JE ;

PERKINS, WH .

AMERICAN HEART JOURNAL, 1962, 63 (04) :528-&

[9]

Hanel J, 1966, Med Welt, V26, P1404

[10]

HANSEL J, 1968, Medizinische Klinik, V63, P919

← 1 2 →